Skip to main content

H.R. 5281

Referred to Committee

Drug Price Transparency in Medicaid Act of 2019

Introduced 12/3/2019•116th Congress•House

Latest Action

Referred to the Subcommittee on Health.

12/4/2019 • House

Summary

Drug Price Transparency in Medicaid Act of 2019

This bill requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with pharmacy benefit managers under Medicaid. The bill also extends funding for retail pharmacy surveys and requires additional information with respect to price concessions, dispensing fees, and survey participation to be made publicly available.

Introduced in House • 12/3/2019

Enter your district to see how this bill affects your community
-

Topics & Subjects

Policy Area: Health
Business recordsCongressional oversightGovernment information and archivesHealth care costs and insuranceHome and outpatient careInflation and pricesMedicaidPrescription drugsPublic contracts and procurementRetail and wholesale tradesState and local government operationsUser charges and fees

Congressional Votes (0)

No recorded votes yet

Roll call votes will appear here as the bill moves through Congress

Related Federal Spending

Sponsor & Cosponsors (2)

Party Breakdown

1
Democrats
1
Republicans
0
Independents

Sponsor

R[
Rep. Carter, Earl L. "Buddy" [R-GA-1]

Republican • GA-1

Sponsored 12/3/2019

Cosponsors (1)

R[
Rep. Cárdenas, Tony [D-CA-29]

D-CA-29

Joined 12/3/2019

Bill Journey

Originated in the House

Introduced

December 3, 2019

Referred to the House Committee on Energy and Commerce.

Committee Review

Floor Debate

Passed Chamber

Other Chamber

President

Enacted into Law

Text Versions (1)

Introduced in House12/3/2019

Details

Bill TypeHR
Current StatusReferred to Committee
Cosponsors1